Skip to main content
Log in

Serum alpha-1-acid glycoprotein and protein binding of disopyramide in patients with congestive heart failure

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Nomura A, Yasuda H, Katoh K, Akimoto T, Miyazaki K, Arita T (1982) Hydralazine and furosemide kinetics. Clin Pharmacol Ther 32: 303–306

    Google Scholar 

  2. Benowitz NL, Meister W (1976) Pharmacokinetics in patients with cardiac failure. Clin Pharmacokinet 1: 389–405

    Google Scholar 

  3. Piafsky KM (1980) Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 5: 246–262

    Google Scholar 

  4. Routledge PA (1986) The plasma protein binding of basic drugs. Br J Clin Pharmacol 22: 499–506

    Google Scholar 

  5. Kremer JMH, Wilting J, Janssen LHM (1988) Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 40: 1–47

    Google Scholar 

  6. Brogden RN, Todd PA (1987) Disopyramide. Drugs 34: 151–187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nomura, A., Yasuda, H., Kobayashi, T. et al. Serum alpha-1-acid glycoprotein and protein binding of disopyramide in patients with congestive heart failure. Eur J Clin Pharmacol 42, 115–116 (1992). https://doi.org/10.1007/BF00314931

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314931

Key words

Navigation